Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. - Wikidata - awgldk - TriplyDB

Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis.

Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis.

http://www.wikidata.org/entity/Q37380362

about

Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response Management of perioperative tumour necrosis factor α inhibitors in rheumatoid arthritis patients undergoing arthroplasty: a systematic review and meta-analysis Beyond fat mass: exploring the role of adipokines in rheumatic diseases Adiponectin and atherosclerosis in rheumatoid arthritis Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity.Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics Pharmacological modulation by celecoxib of cachexia associated with experimental arthritis and atherosclerosis in rabbits.Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases).LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective study Plasma levels of leptin and visfatin in rheumatoid arthritis patients; is there any relationship with joint damage?Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways.Deficits in muscle mass, muscle density, and modified associations with fat in rheumatoid arthritis.The role of adipokines in connective tissue diseases.Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis.Joint-specific assessment of swelling and power Doppler in obese rheumatoid arthritis patients Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis.Smoking Functions as a Negative Regulator of IGF1 and Impairs Adipokine Network in Patients with Rheumatoid Arthritis Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years.Insulin-like Growth Factor 1 and Adiponectin and Associations with Muscle Deficits, Disease Characteristics, and Treatments in Rheumatoid Arthritis.Urinary interleukin-6 as a predictor of radiographic progression in rheumatoid arthritis: A 3-year evaluation.Rheumatic diseases and obesity: adipocytokines as potential comorbidity biomarkers for cardiovascular diseases.Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. A comparative study.Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort.Adipokines as potential biomarkers in rheumatoid arthritis Obesity in rheumatoid arthritis.Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases?Cardiometabolic comorbidities and rheumatic diseases: focus on the role of fat mass and adipokines.What's new in our understanding of the role of adipokines in rheumatic diseases?The influence of ageing on the development and management of rheumatoid arthritis.Adiponectin and leptin: new targets in inflammation.Emerging role of leptin in rheumatoid arthritis.Rheumatoid arthritis and metabolic syndrome.Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations.Adiponectin: is it a biomarker for assessing the disease severity in knee osteoarthritis patients?Baseline adiponectin and leptin levels in predicting an increased risk of disease activity in rheumatoid arthritis: A meta-analysis and systematic review.Prevalence of overweight in Moroccan patients with rheumatoid arthritis and its relationships with disease features.Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritis.Elevated serum resistin in juvenile idiopathic arthritis: relation to categories and disease activity.Patterns and predictors of joint damage as assessed by the rheumatoid arthritis articular damage (RAAD) score in South Africans with established rheumatoid arthritis.

P2860

Q26778275-2396631F-F296-463D-AAB1-78EBBE446A2B Q26786213-05AEA95D-ED13-47A3-8C76-4E1C475882BC Q26864855-24A0184C-CE7E-4885-8FEC-610118658CFC Q33790971-5132368F-6DB1-4E9F-B2FA-BA06A5AB061F Q34228799-FC0DD1CC-1A32-4A49-8D88-D0670EC8BCDA Q34233328-4E50763E-D780-4537-A5E2-FE81727255C2 Q34389006-FC194CC5-44FC-4AC3-9289-9E5D0751B4B6 Q34488394-115FB339-205C-4A29-BC82-CFBB38467E7A Q34901953-A6687849-BB86-47A2-908B-CA10394EA3A7 Q35065164-063366CC-1B49-4CAB-8EC3-93CBF332A803 Q35907720-41864641-0C2A-45CC-B937-20715245EA0F Q36001279-E40566C2-36D6-4152-AD91-CE7C8DAF2F62 Q36095970-953ECF61-795F-47F4-A74E-EA9E190A471E Q36148660-38847C03-8DD8-44DF-8BD1-CA8C897B623B Q36297290-358F9E7A-0638-42F4-B1CF-014192AC1A96 Q36464831-1BC9CB28-E1D0-4B08-B91D-1ACCB4CCDA48 Q36528874-0E57402A-8081-4E86-ABF0-2FD8CA64E520 Q36693727-FDB8FB9B-E739-4B48-A84C-6689F384F457 Q36732733-B52751D2-2FED-40A5-9F94-06B9892EB047 Q36732747-8F07750E-BC67-43F0-95F6-79B3F58BAB6B Q37330396-17856FC1-B90A-4060-A1F4-DCE6879ED0EB Q37385755-4BBF0D8F-2610-49E9-8481-F3966DA34F5D Q37389102-D727B2E1-73B6-4772-9F1A-DFB0611F8F6C Q37690729-85FEABDB-F5AC-471E-BD4F-E9AFF5F6E178 Q37700750-1B67D104-1D27-4823-9929-B7D9CEB18AD0 Q37801496-7614DBFF-6107-48FA-B73C-16297A00DE1E Q37845275-233F16F2-4D53-49FC-81E4-947674E99957 Q37869467-28937308-B216-42EA-9A6E-37CB0EC69A98 Q37909903-94818F1C-4291-4C4B-8E68-2F712086C8D6 Q38115131-87723D97-EF94-4C0B-B30A-34C419044F8A Q38120068-988D5B79-0935-4114-8680-5EF6031983E9 Q38209820-C7709A10-119B-4C22-AC59-EEC5CF094905 Q38236740-0D33E727-72FD-443A-9489-8B6739EA2E4F Q38763702-B4035053-326A-412C-80A7-8C430D604A51 Q38945485-38DB54C7-E372-46A4-A7A0-E00734D8B7F4 Q38968920-DC5A1441-CA64-4110-B01F-2226A71D0605 Q39091655-D1C44FCD-3D25-450A-8201-9D49A7A9C644 Q39710835-184AFDE8-13E2-4D55-9E7A-4CAD9EDB4D24 Q46149920-39098741-D468-4D5A-A03D-DDF95EE96C96 Q46176650-61A46615-9111-4632-8036-56C93BD1BFDB

P2860

Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis.

http://www.wikidata.org/entity/Q37380362

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adiponectin is a mediator of t ...... amage in rheumatoid arthritis.

@en

Adiponectin is a mediator of t ...... amage in rheumatoid arthritis.

@nl

type

label

Adiponectin is a mediator of t ...... amage in rheumatoid arthritis.

@en

Adiponectin is a mediator of t ...... amage in rheumatoid arthritis.

@nl

prefLabel

Adiponectin is a mediator of t ...... amage in rheumatoid arthritis.

@en

Adiponectin is a mediator of t ...... amage in rheumatoid arthritis.

@nl

P1433

Q37380362-19E50C57-63D3-45A3-AB97-706885B143F6

P1476

Q37380362-5D4D82BF-95B6-4931-BAEA-6FD3852F3FE0

P2093

Q37380362-4D2D1FC3-023C-4511-A250-3F801BC34BDB

Q37380362-4E151530-6E37-475C-9000-A4BC9F6BB580

Q37380362-56CD85EB-6FB2-46CA-9256-B636A77980BC

Q37380362-7C125EA4-199F-401A-B1C7-BD367AAA543B

P2860

Q37380362-00944C3C-47C7-4CC9-A630-2D049295CFB8

Q37380362-0F190DF6-6459-48EB-A822-390E951B6F18

Q37380362-1566182D-ED5B-4B49-ADD4-C8251B2B8037

Q37380362-1E7BD963-FC23-4F30-9AE6-30F303304D5B

Q37380362-258BA78B-9D7D-4091-A78C-5489CE37958D

Q37380362-283EBD3C-9790-4042-8880-915EF4429F8C

Q37380362-29B0FAE2-C45D-4824-A11D-63F56ACCF8DF

Q37380362-2A700114-09FC-40DA-A068-376274C5DFE3

Q37380362-38723635-6F39-48BC-AC76-7624B0D4EC5A

Q37380362-45C1551B-4DC0-4EB5-A2EB-F5C471A9CD40

P304

Q37380362-24710B83-E5D6-4608-8D7F-AFFEDCB41322

P31

Q37380362-DD87C95E-E409-4DFA-89DF-787F57D9FE58

P356

Q37380362-1CF9D193-790C-490D-8DC4-401A74C98A4E

P433

Q37380362-9FBC0F08-E2FC-464D-B4BA-0224ABB89B05

P478

Q37380362-5C8130D2-986E-47B3-B372-D009B61E71BC

P50

Q37380362-45D3ABD4-3B26-43A0-857A-5A882C321DF5

P577

Q37380362-300CE342-5C7A-40F6-8155-029AF493DE6D

P5875

Q37380362-B5323042-A8B9-4026-A948-283461CB11FB

P698

Q37380362-A85E352D-174C-4FB2-A296-DFA431E597AD

P932

Q37380362-572D0EFF-709B-4B95-8CB5-B9FDF537C277

P356

P1433

Arthritis & Rheumatology

P1476

Adiponectin is a mediator of t ...... amage in rheumatoid arthritis.

@en

P2093

Clifton O Bingham

http://www.w3.org/2001/XMLSchema#string

Joan M Bathon

http://www.w3.org/2001/XMLSchema#string

Jon T Giles

http://www.w3.org/2001/XMLSchema#string

William M Scott

http://www.w3.org/2001/XMLSchema#string

P2860

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

Adipokines, insulin resistance, and coronary artery calcification.

A general model for testing mediation and moderation effects

Adiponectin differentially regulates cytokines in porcine macrophages.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease.

Leptin consumption in the inflamed joints of patients with rheumatoid arthritis

P304

1248-1256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.24789

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P50

Matthew Allison

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26774415

http://www.w3.org/2001/XMLSchema#string

P698

19714593

http://www.w3.org/2001/XMLSchema#string

P932

2759038

http://www.w3.org/2001/XMLSchema#string